Reply

Ann Neurol. 2016 May;79(5):868. doi: 10.1002/ana.24629. Epub 2016 Mar 22.

Gemma Tell-Martí^{1

2}, Joan Anton Puig-Butille^{2

3}, Miriam Potrony¹, Celia Badenas^{2

3}, Montserrat Milà^{2

3}, Josep Malvehy^{1

2}, María José Martí⁴, Mario Ezquerra⁴, Rubén Fernández-Santiago⁴, Susana Puig^{1

2

5}

¹ Dermatology Department, Melanoma Unit, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
² Center for Networked Biomedical Research on Rare Diseases (CIBERER), Carlos III Health Institute (ISCIII), Barcelona, Spain.
³ Biochemical and Molecular Genetics Service, Hospital Clínic and August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
⁴ Laboratory of Neurodegenerative Disorders, Department of Clinical and Experimental Neurology, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Hospital Clínic of Barcelona, Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Barcelona, Spain.
⁵ Medicine Department, University of Barcelona (UB), Barcelona, Spain.

No abstract available